Stay updated on PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Sign up to get notified when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.

Latest updates to the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page
- Check7 days agoChange DetectedThe page now shows revision v3.6.4, replacing the previous v3.6.3. This appears to be a software maintenance update rather than a modification to study content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page version or metadata rather than substantive content changes.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page shows Revision: v3.6.2 instead of v3.6.0, reflecting an update to the site's underlying software version.SummaryDifference0.1%

- Check50 days agoChange DetectedRecruitment status on the study page was updated to indicate no longer seeking participants, reflecting that enrollment has ended. The page also gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment heading formatting to align with the new layout.SummaryDifference0.5%

- Check57 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, reflecting a new version of the study record. This update indicates that the study page content and metadata have been refreshed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdds a bibliographic reference to Kashyap et al.’s 2025 J Nucl Med article to the Publications section, expanding the documented related research. The update does not alter study design, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.